Registry expected to pair Ignite’s reimbursed RPPA platform with structured outcomes tracking across ADC and immunotherapy regimens; initiative expected to generate an estimated ~$13 million for ...

A translational oncology research initiative by Prof. Stephan Singer at University Hospital Tübingen enables therapy selection, measuring more than 10,000 proteins in FFPE biopsies to reveal ...

MOUNTAIN VIEW, Calif. & GOLDEN, Colo. & HONG KONG, June 09, 2026--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt"), a qualified acquisition corp and Ignite Proteomics, LLC ("Ignite", or "Ignite Proteomics"), a ...

The global soy protein isolate market is experiencing consistent expansion as industries increasingly adopt plant-based protein solutions to meet rising demand for nutrition-focused food products.

ARNHEM, THE NETHERLANDS — Interest in functional ingredients, particularly protein and fiber, continues to rise as consumers remain increasingly focused on the health and wellness benefits of their ...

Ignite Proteomics, LLC (“Ignite” or “Ignite Proteomics”) a subsidiary of Aditxt, Inc. (NASDAQ: ADTX), today announced the launch of a prospective oncology registry enrolling up to 10,000 patients. The ...